CAH 80.60 Cardinal Health $CAH Hit a 52 week high of 81.04 Closing the day 09:45 at 80.60 -0.41 -0.51% With a day low of 80.61 and a total volume of 78,198.
CAH Recent Posts: http://investorshangout.com/Cardinal-Health-Inc-CAH-50431/
CAH Cardinal Health Recent Headline News
Jim Cramer: Which Stocks Stand Out as Winners? Here's My List
at The Street - Tue Nov 18, 10:47AM CST
There's a powerful collection of 'what's working.'
HON: 96.23 (-0.60), JAH: 67.62 (+0.59), CAH: 80.36 (-0.65), WMT: 84.58 (+0.79), PDCO: 46.46 (-0.15), EAT: 54.17 (+0.20), UPS: 105.54 (-0.49), JACK: 74.46 (+2.96), DLTR: 61.63 (-0.36), TGT: 70.69 (+3.18), COST: 139.60 (+0.39), AAL: 44.76 (-0.29), DG: 63.45 (-2.72), LOW: 61.69 (+3.16), MSFT: 48.14 (-0.60), HSIC: 132.24 (-0.15), BCR: 166.06 (-1.30), MCK: 206.01 (-1.98), IP: 54.72 (-0.26), EW: 126.23 (-1.65), FDO: 78.15 (-0.70), AZO: 568.93 (+0.34), MCD: 96.79 (+0.38), SHW: 240.31 (-1.01), XRAY: 53.00 (-0.11), AN: 58.00 (+0.27), F: 15.36 (-0.14), ACT: 268.00 (-1.60), BDX: 130.24 (-0.70), VRX: 142.62 (+0.68), MDT: 72.01 (-0.46), SNA: 135.27 (-0.75), GMCR: 155.81 (-1.29), AGN: 213.35 (-0.02), KMX: 55.18 (+0.05), YHOO: 50.45 (-1.30), WHR: 178.08 (+0.86), CMG: 656.63 (-1.46), AAPL: 114.68 (-0.79), AMZN: 325.87 (+0.94), HD: 96.70 (+0.72), ORLY: 178.69 (+0.12), FRGI: 56.21 (+0.19), ABC: 89.05 (-0.71), TJX: 61.99 (+0.35), GM: 32.15 (-0.12), JWN: 73.35 (-0.17), ROST: 81.83 (+0.55)
Strength Seen in Neostem (NBS): Stock Moves 9.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 8:46AM CST
Neostem (NBS) was a big mover last session, with shares surging over 38% on the day.
ABC: 89.05 (-0.71), BCR: 166.06 (-1.30), CAH: 80.36 (-0.65), NBS: 4.62 (-0.16)
LabCorp Shows Strength on Covance Buyout Plan, Robust Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 3:34PM CST
On Nov 17, 2014, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
ABC: 89.05 (-0.71), BCR: 166.06 (-1.30), CAH: 80.36 (-0.65), UNH: 97.48 (-0.71), LH: 101.41 (+0.23), BMY: 58.65 (-0.05)
Cardinal Health Earnings In Retrospect: Up 2.8% in the Last 18 Days (CAH)
Comtex SmarTrend(R) - Mon Nov 17, 9:23AM CST
When Cardinal Health (NYSE:CAH) reported earnings 18 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.96 on sales of $22.5 billion. Cardinal Health actually reported earnings of $1.00 per share on sales of $24.1 billion, beating EPS estimates by $0.04 and beating revenue estimates by $1.5 billion. Since the company's report, shares of Cardinal Health have risen from $78.19 to $80.35, representing a gain of 2.8% in the past 18 days.
CAH: 80.36 (-0.65)
Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020
M2 - Mon Nov 17, 4:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/llklcc/global) has announced the addition of the "Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020" report to their offering. The nuclear medicine market by indication is segmented as oncology, cardiology, inflammation, nephrology, neurology, lymphology, thyroid glands, and gastro intestinal. Cardiology holds the largest share in 2013 in SPECT nuclear medicine market whereas nephrology is the fastest growing application of this segment. Increasing incidence of cardiac ailments, aging population, and preference for non invasive diagnostic procedures are driving the market for cardiology segment. Oncology contributes to the largest share of around $1 billion and is also the fastest growing segment in PET market with a CAGR of more than 7%. Nephrology is the fastest growing segment in the therapeutics. Increase in therapeutic application, public awareness, use of hybrid imaging, technological advancements, cyclotron production of radiopharmaceuticals, efficient diagnosis and treatments, emerging radioisotopes and replacement of traditional equipment are factors or opportunities expected to drive the nuclear medicine market. However, stringent regulatory issues, supply shortage, radio toxicity, high cost and huge investment are factors hindering the market growth during the forecasted period. North America holds the largest share for nuclear medicine market, followed by Europe. The U.S. market is highly supported by the Mo-99 production of NRU reactor (Canada) and ongoing researches in different clinical institutes such as National Cancer Institute, Avid Radiopharmaceuticals and so on. Besides developed markets, the Asia-Pacific region is expected to show a remarkable growth in the coming years. Asia-Pacific (APAC) and Rest of the World are poised to grow at a CAGR of more than 6% and 8% respectively by 2020. This region growth is attributed to aging population, rise in public awareness. Countries like China, India, Australia, and Brazil will be major contributors to the growth of the market. Reasons to Buy: - Nuclear medicine/Radiopharmaceuticals usage and demand by various end-users across the globe - Emerging isotopes as well as alternative isotopes for use both in the SPECT and PET segments - Emerging applications in Nuclear Medicine - Regulations and Reimbursement scenario - Stable isotopes study being a value addition - Competitive landscaping and Major player profiles Key Topics Covered: 1. Summary 2. Introduction 3. Market Overview 4. Global Radiopharmaceutical market, by End-User 5. Global Radiopharmaceutical market, by Application 6. Stable Isotopes 7. Geographic Analysis 8. Competitors Landscape 9. Major Company Profiles - CIL - Cardinal Health, Inc. - GE Healthcare - IBA Group - Isotec, Inc. (Sigma-Aldrich) - Lantheus Medical Imaging, Inc. - Mallinckrodt Plc - NTP Radioisotopes - Nordion Inc - Taiyo Nippon Sanso Corporation For more information visit http://www.researchandmarkets.com/research/llklcc/global
CAH: 80.36 (-0.65), NDZ: 12.99 (-0.01)
Cardinal Health Launches Online Tool To Help Retail Pharmacies Make It Easier For Patients To Compare Medicare Part D Plans
PR Newswire - Thu Nov 13, 7:30AM CST
With the window for Medicare enrollment open from mid-October through Dec. 7, Cardinal Health recently launched a new online tool, developed by eHealth, Inc. (NASDAQ: EHTH), that its retail pharmacy customers can use to help their patients compare Medicare Part D prescription drug plans.
CAH: 80.36 (-0.65), EHTH: 22.94 (+0.13)
Canada Compression Therapy Market Outlook to 2020: SIGVARIS, Inc., Covidien plc and BSN medical GmbH Leads the Market
M2 - Thu Nov 13, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/n5g6ff/canada) has announced the addition of the "Canada Compression Therapy Market Outlook to 2020" report to their offering. "Canada Compression Therapy Market Outlook to 2020", provides key market data on the Canada Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Compression Therapy market. - Global corporate-level profiles of key companies operating within the Canada Compression Therapy. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages, Anti Embolism Stockings and Diabetic Compression Socks) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - Smith & Nephew Plc - 3M Health Care Ltd. - Mego Afek AC LTd. - DJO Global, Inc. - Bio Compression Systems, Inc. - medi GmbH & Co. KG - ConvaTec Inc. - Lohmann & Rauscher GmbH & Co. KG - Systagenix Wound Management Limited - B. Braun Melsungen AG - Derma Sciences, Inc. - Medline Industries, Inc. - Laboratoires Urgo S.A. - Talley Group Limited - ArjoHuntleigh - Molnlycke Health Care AB - Gloria Med S.p.A. - Cardinal Health, Inc. - Juzo USA For more information visit http://www.researchandmarkets.com/research/n5g6ff/canada
DSCI: 8.46 (-0.07), SNN: 33.79 (+0.01), CAH: 80.36 (-0.65)
Health Care Sector Stocks Highlight - AmerisourceBergen, Cardinal Health, McKesson, Health Net, and WellCare Health Plans
PR Newswire - Wed Nov 12, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: AmerisourceBergen Corporation (NYSE: ABC), Cardinal Health Inc. (NYSE: CAH), McKesson Corporation (NYSE: MCK), Health Net Inc. (NYSE: HNT), and WellCare Health Plans Inc. (NYSE: WCG). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, November 11, 2014, the NASDAQ Composite ended at 4,660.56, up 0.19%, the Dow Jones Industrial Average advanced 0.01%, to finish the day at 17,614.90, and the S&P 500 closed at 2,039.68, up 0.07%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 785.77, up 0.35%, with the index also advancing 12.25% in the last three months. Register for your complimentary reports on these five stocks at:
ABC: 89.05 (-0.71), MCK: 206.01 (-1.98), CAH: 80.36 (-0.65), WCG: 69.85 (-0.11), HNT: 51.90 (+0.09)
Global Disposable Gloves Market Opportunities and Outlook 2020: Market is Expected to be Valued at $7.9 Billion in 2020
M2 - Tue Nov 11, 8:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/jfrtmb/global_disposable) has announced the addition of the "Global Disposable Gloves Market (Product Types, Forms, End-Users, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 " report to their offering. The global disposable gloves market is estimated to grow at CAGR of 6.2% over the period 2014-2020 and is expected to be valued at $7.9 billion in 2020 The global disposable gloves product market can also be segmented into powdered and non-powdered disposable gloves. Powdered gloves are widely used in the market owing to their high sterility, disposable nature and affordable cost. Owing to such benefits and consequent high usage/adoption rate by customers, powdered gloves garneredhigh volume (billion gloves) and -71.5% of the market in 2013. On the basis of geography, the global disposable gloves market is segmented into North America, Europe, Asia Pacific and Rest of World. On account of higher purchasing power and stringenthealthcare regulations in the developed regions, such regions have garnered majority market share of the global disposable gloves market. As elaborated earlier, many companies aim to develop and market newer variants of disposable gloves; for instance, Dynarex Corporation launched black nitrile exam gloves' that are non-sterile, powder free and ambidextrous and commonly used across range of industries. Companies profiled in the report are Ansell Healthcare, Hartalega Holdings Berhad, Supermax Corporation Berhad, Kossan Rubber industries ltd, Rubberex, Top Glove Corporation Berhad, AdventaBerhad, Cardinal Health, Inc., Dynarex Corporation. Key findings of the study: - Polyethylene disposable gloves segment market will grow at a CAGR of 10.2% during the forecast period, fastest among all disposable gloves types - Within disposable gloves market by various forms, powder-free gloves market would be most lucrative during forecast period - Within disposable gloves market by end user, non-medical gloves, is the fastest growing disposable gloves segment; whereas, medical gloves would remain segment with largest market share i.e., in volume (billion gloves) and value (59.6% share) in 2020 - Within disposable gloves market by application, in context of medical gloves, surgical gloves constitute second largest segment in volume (billion gloves) by 2020. Another type of medical gloves i.e. examination gloves, would garner about 57.0% market share by 2020 - Clean room application would outrun other non-medical gloves' application market share by 2020 - Asia-Pacific would be one of the lucrative markets, both in terms of size and growth. Asia-Pacific would reach $1.7 billion by 2020, with highest CAGR of 8.6% (as compared to other regional markets) Companies profiled in this report are Ansell Healthcare, Hartalega Holdings Berhad, Supermax Corporation Berhad, Kossan Rubber industries ltd, Rubberex, Top Glove Corporation Berhad, Adventa Berhad, Cardinal Health, Inc., and Dynarex Corporation. For more information visit http://www.researchandmarkets.com/research/jf...disposable
CAH: 80.36 (-0.65)
Cardinal Health commences public offering of USD1.2bn new senior notes
M2 - Mon Nov 10, 6:55AM CST
Health care services company Cardinal Health (NYSE:CAH) announced on Friday that it has launched its public offering to sell USD1.2bn aggregate principal amount of senior notes due 2019, senior notes due 2024 and senior notes due 2044 (new notes).
CAH: 80.36 (-0.65)
Dividend Contenders, Future Champions Or Future Failures: Part 6
Stan Stafford - at Seeking Alpha - Fri Nov 07, 5:13PM CST
PRGO: 159.20 (-0.74), NVO: 44.57 (+0.35), CAH: 80.36 (-0.65), TEVA: 57.49 (+0.26)
Cardinal Health Announces Offering of Senior Notes and Redemption of Outstanding Senior Notes
PR Newswire - Fri Nov 07, 8:02AM CST
Cardinal Health today announced that it has commenced a registered public offering to sell $1.2 billion aggregate principal amount of senior notes due 2019, senior notes due 2024 and senior notes due 2044 (collectively, the "New Notes"
. Deutsche Bank Securities Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers for the offering.
JPM: 60.23 (-0.30), CAH: 80.36 (-0.65), DB: 30.75 (+0.15)
Cardinal Health's board reports USD0.3425 per share dividend
M2 - Thu Nov 06, 7:48AM CST
Cardinal Health (NYSE:CAH) declared on Wednesday that its board of directors approved a quarterly dividend of USD0.3425 per share of the company's stock.
CAH: 80.36 (-0.65)
Cardinal Health Inc declares $0.3425 dividend
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:54PM CST
CAH: 80.36 (-0.65)
Cardinal Health Announces Quarterly Dividend and Preliminary Shareholder Voting Results at 2014 Annual Meeting
PR Newswire - Wed Nov 05, 3:10PM CST
Cardinal Health today announced that the board of directors approved a regular quarterly dividend of $0.3425 per share, payable Jan. 15, 2015, to shareholders of record on Jan. 2, 2015.
CAH: 80.36 (-0.65)
Cardinal Health Rises 1.18% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Nov 04, 5:22PM CST
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $78.48 to a high of $79.73. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $79.13 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 80.36 (-0.65)
Cardinal Health Set to Possibly Pullback After Yesterday's Rally of 1.18%
Comtex SmarTrend(R) - Tue Nov 04, 5:21PM CST
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $78.48 to a high of $79.73. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $79.13 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 80.36 (-0.65)
Financial Results, Facility Opening, and Management Changes - Research Reports on Norfolk, Cardinal, CSX, Viacom and Carnival
PR Newswire - Tue Nov 04, 8:10AM CST
Today, Analysts Review released its research reports regarding Norfolk Southern Corp. (NYSE: NSC), Cardinal Health Inc. (NYSE: CAH), CSX Corporation (NYSE: CSX), Viacom, Inc. (NASDAQ: VIAB) and Carnival Corporation (NYSE: CCL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7672-100free.
NSC: 114.82 (-0.56), CCL: 41.73 (-0.54), CAH: 80.36 (-0.65), CSX: 36.62 (-0.05), VIAB: 73.08 (-0.67)
How Can Health Plans Make MTM Services a Cornerstone Benefit for Their Members?
PR Newswire - Mon Nov 03, 8:41AM CST
Healthcare leaders are being pushed hard across the board to lower costs while raising quality. Medication Therapy Management (MTM) has been hailed by many, including the federal government, as one way to accomplish this important goal, especially in Medicare Part D. In fact, the Center for Medicare & Medicaid Services (CMS) calls MTM a "cornerstone" of Part D's future and a practice that will "serve as a model for achieving quality."
CAH: 80.36 (-0.65)
Cardinal Health (CAH) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Sat Nov 01, 9:37PM CDT
The following Cardinal Health (CAH) conference call took place on October 30, 2014, 08:30 AM ET. This is a transcript of that earnings call:
CAH: 80.36 (-0.65)
CAH Recent Posts: http://investorshangout.com/Cardinal-Health-Inc-CAH-50431/
CAH Cardinal Health Recent Headline News
Jim Cramer: Which Stocks Stand Out as Winners? Here's My List
at The Street - Tue Nov 18, 10:47AM CST
There's a powerful collection of 'what's working.'
HON: 96.23 (-0.60), JAH: 67.62 (+0.59), CAH: 80.36 (-0.65), WMT: 84.58 (+0.79), PDCO: 46.46 (-0.15), EAT: 54.17 (+0.20), UPS: 105.54 (-0.49), JACK: 74.46 (+2.96), DLTR: 61.63 (-0.36), TGT: 70.69 (+3.18), COST: 139.60 (+0.39), AAL: 44.76 (-0.29), DG: 63.45 (-2.72), LOW: 61.69 (+3.16), MSFT: 48.14 (-0.60), HSIC: 132.24 (-0.15), BCR: 166.06 (-1.30), MCK: 206.01 (-1.98), IP: 54.72 (-0.26), EW: 126.23 (-1.65), FDO: 78.15 (-0.70), AZO: 568.93 (+0.34), MCD: 96.79 (+0.38), SHW: 240.31 (-1.01), XRAY: 53.00 (-0.11), AN: 58.00 (+0.27), F: 15.36 (-0.14), ACT: 268.00 (-1.60), BDX: 130.24 (-0.70), VRX: 142.62 (+0.68), MDT: 72.01 (-0.46), SNA: 135.27 (-0.75), GMCR: 155.81 (-1.29), AGN: 213.35 (-0.02), KMX: 55.18 (+0.05), YHOO: 50.45 (-1.30), WHR: 178.08 (+0.86), CMG: 656.63 (-1.46), AAPL: 114.68 (-0.79), AMZN: 325.87 (+0.94), HD: 96.70 (+0.72), ORLY: 178.69 (+0.12), FRGI: 56.21 (+0.19), ABC: 89.05 (-0.71), TJX: 61.99 (+0.35), GM: 32.15 (-0.12), JWN: 73.35 (-0.17), ROST: 81.83 (+0.55)
Strength Seen in Neostem (NBS): Stock Moves 9.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 8:46AM CST
Neostem (NBS) was a big mover last session, with shares surging over 38% on the day.
ABC: 89.05 (-0.71), BCR: 166.06 (-1.30), CAH: 80.36 (-0.65), NBS: 4.62 (-0.16)
LabCorp Shows Strength on Covance Buyout Plan, Robust Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 3:34PM CST
On Nov 17, 2014, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
ABC: 89.05 (-0.71), BCR: 166.06 (-1.30), CAH: 80.36 (-0.65), UNH: 97.48 (-0.71), LH: 101.41 (+0.23), BMY: 58.65 (-0.05)
Cardinal Health Earnings In Retrospect: Up 2.8% in the Last 18 Days (CAH)
Comtex SmarTrend(R) - Mon Nov 17, 9:23AM CST
When Cardinal Health (NYSE:CAH) reported earnings 18 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.96 on sales of $22.5 billion. Cardinal Health actually reported earnings of $1.00 per share on sales of $24.1 billion, beating EPS estimates by $0.04 and beating revenue estimates by $1.5 billion. Since the company's report, shares of Cardinal Health have risen from $78.19 to $80.35, representing a gain of 2.8% in the past 18 days.
CAH: 80.36 (-0.65)
Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020
M2 - Mon Nov 17, 4:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/llklcc/global) has announced the addition of the "Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020" report to their offering. The nuclear medicine market by indication is segmented as oncology, cardiology, inflammation, nephrology, neurology, lymphology, thyroid glands, and gastro intestinal. Cardiology holds the largest share in 2013 in SPECT nuclear medicine market whereas nephrology is the fastest growing application of this segment. Increasing incidence of cardiac ailments, aging population, and preference for non invasive diagnostic procedures are driving the market for cardiology segment. Oncology contributes to the largest share of around $1 billion and is also the fastest growing segment in PET market with a CAGR of more than 7%. Nephrology is the fastest growing segment in the therapeutics. Increase in therapeutic application, public awareness, use of hybrid imaging, technological advancements, cyclotron production of radiopharmaceuticals, efficient diagnosis and treatments, emerging radioisotopes and replacement of traditional equipment are factors or opportunities expected to drive the nuclear medicine market. However, stringent regulatory issues, supply shortage, radio toxicity, high cost and huge investment are factors hindering the market growth during the forecasted period. North America holds the largest share for nuclear medicine market, followed by Europe. The U.S. market is highly supported by the Mo-99 production of NRU reactor (Canada) and ongoing researches in different clinical institutes such as National Cancer Institute, Avid Radiopharmaceuticals and so on. Besides developed markets, the Asia-Pacific region is expected to show a remarkable growth in the coming years. Asia-Pacific (APAC) and Rest of the World are poised to grow at a CAGR of more than 6% and 8% respectively by 2020. This region growth is attributed to aging population, rise in public awareness. Countries like China, India, Australia, and Brazil will be major contributors to the growth of the market. Reasons to Buy: - Nuclear medicine/Radiopharmaceuticals usage and demand by various end-users across the globe - Emerging isotopes as well as alternative isotopes for use both in the SPECT and PET segments - Emerging applications in Nuclear Medicine - Regulations and Reimbursement scenario - Stable isotopes study being a value addition - Competitive landscaping and Major player profiles Key Topics Covered: 1. Summary 2. Introduction 3. Market Overview 4. Global Radiopharmaceutical market, by End-User 5. Global Radiopharmaceutical market, by Application 6. Stable Isotopes 7. Geographic Analysis 8. Competitors Landscape 9. Major Company Profiles - CIL - Cardinal Health, Inc. - GE Healthcare - IBA Group - Isotec, Inc. (Sigma-Aldrich) - Lantheus Medical Imaging, Inc. - Mallinckrodt Plc - NTP Radioisotopes - Nordion Inc - Taiyo Nippon Sanso Corporation For more information visit http://www.researchandmarkets.com/research/llklcc/global
CAH: 80.36 (-0.65), NDZ: 12.99 (-0.01)
Cardinal Health Launches Online Tool To Help Retail Pharmacies Make It Easier For Patients To Compare Medicare Part D Plans
PR Newswire - Thu Nov 13, 7:30AM CST
With the window for Medicare enrollment open from mid-October through Dec. 7, Cardinal Health recently launched a new online tool, developed by eHealth, Inc. (NASDAQ: EHTH), that its retail pharmacy customers can use to help their patients compare Medicare Part D prescription drug plans.
CAH: 80.36 (-0.65), EHTH: 22.94 (+0.13)
Canada Compression Therapy Market Outlook to 2020: SIGVARIS, Inc., Covidien plc and BSN medical GmbH Leads the Market
M2 - Thu Nov 13, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/n5g6ff/canada) has announced the addition of the "Canada Compression Therapy Market Outlook to 2020" report to their offering. "Canada Compression Therapy Market Outlook to 2020", provides key market data on the Canada Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Compression Therapy market. - Global corporate-level profiles of key companies operating within the Canada Compression Therapy. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages, Anti Embolism Stockings and Diabetic Compression Socks) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - Smith & Nephew Plc - 3M Health Care Ltd. - Mego Afek AC LTd. - DJO Global, Inc. - Bio Compression Systems, Inc. - medi GmbH & Co. KG - ConvaTec Inc. - Lohmann & Rauscher GmbH & Co. KG - Systagenix Wound Management Limited - B. Braun Melsungen AG - Derma Sciences, Inc. - Medline Industries, Inc. - Laboratoires Urgo S.A. - Talley Group Limited - ArjoHuntleigh - Molnlycke Health Care AB - Gloria Med S.p.A. - Cardinal Health, Inc. - Juzo USA For more information visit http://www.researchandmarkets.com/research/n5g6ff/canada
DSCI: 8.46 (-0.07), SNN: 33.79 (+0.01), CAH: 80.36 (-0.65)
Health Care Sector Stocks Highlight - AmerisourceBergen, Cardinal Health, McKesson, Health Net, and WellCare Health Plans
PR Newswire - Wed Nov 12, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: AmerisourceBergen Corporation (NYSE: ABC), Cardinal Health Inc. (NYSE: CAH), McKesson Corporation (NYSE: MCK), Health Net Inc. (NYSE: HNT), and WellCare Health Plans Inc. (NYSE: WCG). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, November 11, 2014, the NASDAQ Composite ended at 4,660.56, up 0.19%, the Dow Jones Industrial Average advanced 0.01%, to finish the day at 17,614.90, and the S&P 500 closed at 2,039.68, up 0.07%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 785.77, up 0.35%, with the index also advancing 12.25% in the last three months. Register for your complimentary reports on these five stocks at:
ABC: 89.05 (-0.71), MCK: 206.01 (-1.98), CAH: 80.36 (-0.65), WCG: 69.85 (-0.11), HNT: 51.90 (+0.09)
Global Disposable Gloves Market Opportunities and Outlook 2020: Market is Expected to be Valued at $7.9 Billion in 2020
M2 - Tue Nov 11, 8:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/jfrtmb/global_disposable) has announced the addition of the "Global Disposable Gloves Market (Product Types, Forms, End-Users, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 " report to their offering. The global disposable gloves market is estimated to grow at CAGR of 6.2% over the period 2014-2020 and is expected to be valued at $7.9 billion in 2020 The global disposable gloves product market can also be segmented into powdered and non-powdered disposable gloves. Powdered gloves are widely used in the market owing to their high sterility, disposable nature and affordable cost. Owing to such benefits and consequent high usage/adoption rate by customers, powdered gloves garneredhigh volume (billion gloves) and -71.5% of the market in 2013. On the basis of geography, the global disposable gloves market is segmented into North America, Europe, Asia Pacific and Rest of World. On account of higher purchasing power and stringenthealthcare regulations in the developed regions, such regions have garnered majority market share of the global disposable gloves market. As elaborated earlier, many companies aim to develop and market newer variants of disposable gloves; for instance, Dynarex Corporation launched black nitrile exam gloves' that are non-sterile, powder free and ambidextrous and commonly used across range of industries. Companies profiled in the report are Ansell Healthcare, Hartalega Holdings Berhad, Supermax Corporation Berhad, Kossan Rubber industries ltd, Rubberex, Top Glove Corporation Berhad, AdventaBerhad, Cardinal Health, Inc., Dynarex Corporation. Key findings of the study: - Polyethylene disposable gloves segment market will grow at a CAGR of 10.2% during the forecast period, fastest among all disposable gloves types - Within disposable gloves market by various forms, powder-free gloves market would be most lucrative during forecast period - Within disposable gloves market by end user, non-medical gloves, is the fastest growing disposable gloves segment; whereas, medical gloves would remain segment with largest market share i.e., in volume (billion gloves) and value (59.6% share) in 2020 - Within disposable gloves market by application, in context of medical gloves, surgical gloves constitute second largest segment in volume (billion gloves) by 2020. Another type of medical gloves i.e. examination gloves, would garner about 57.0% market share by 2020 - Clean room application would outrun other non-medical gloves' application market share by 2020 - Asia-Pacific would be one of the lucrative markets, both in terms of size and growth. Asia-Pacific would reach $1.7 billion by 2020, with highest CAGR of 8.6% (as compared to other regional markets) Companies profiled in this report are Ansell Healthcare, Hartalega Holdings Berhad, Supermax Corporation Berhad, Kossan Rubber industries ltd, Rubberex, Top Glove Corporation Berhad, Adventa Berhad, Cardinal Health, Inc., and Dynarex Corporation. For more information visit http://www.researchandmarkets.com/research/jf...disposable
CAH: 80.36 (-0.65)
Cardinal Health commences public offering of USD1.2bn new senior notes
M2 - Mon Nov 10, 6:55AM CST
Health care services company Cardinal Health (NYSE:CAH) announced on Friday that it has launched its public offering to sell USD1.2bn aggregate principal amount of senior notes due 2019, senior notes due 2024 and senior notes due 2044 (new notes).
CAH: 80.36 (-0.65)
Dividend Contenders, Future Champions Or Future Failures: Part 6
Stan Stafford - at Seeking Alpha - Fri Nov 07, 5:13PM CST
PRGO: 159.20 (-0.74), NVO: 44.57 (+0.35), CAH: 80.36 (-0.65), TEVA: 57.49 (+0.26)
Cardinal Health Announces Offering of Senior Notes and Redemption of Outstanding Senior Notes
PR Newswire - Fri Nov 07, 8:02AM CST
Cardinal Health today announced that it has commenced a registered public offering to sell $1.2 billion aggregate principal amount of senior notes due 2019, senior notes due 2024 and senior notes due 2044 (collectively, the "New Notes"
. Deutsche Bank Securities Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers for the offering. JPM: 60.23 (-0.30), CAH: 80.36 (-0.65), DB: 30.75 (+0.15)
Cardinal Health's board reports USD0.3425 per share dividend
M2 - Thu Nov 06, 7:48AM CST
Cardinal Health (NYSE:CAH) declared on Wednesday that its board of directors approved a quarterly dividend of USD0.3425 per share of the company's stock.
CAH: 80.36 (-0.65)
Cardinal Health Inc declares $0.3425 dividend
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:54PM CST
CAH: 80.36 (-0.65)
Cardinal Health Announces Quarterly Dividend and Preliminary Shareholder Voting Results at 2014 Annual Meeting
PR Newswire - Wed Nov 05, 3:10PM CST
Cardinal Health today announced that the board of directors approved a regular quarterly dividend of $0.3425 per share, payable Jan. 15, 2015, to shareholders of record on Jan. 2, 2015.
CAH: 80.36 (-0.65)
Cardinal Health Rises 1.18% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Nov 04, 5:22PM CST
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $78.48 to a high of $79.73. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $79.13 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 80.36 (-0.65)
Cardinal Health Set to Possibly Pullback After Yesterday's Rally of 1.18%
Comtex SmarTrend(R) - Tue Nov 04, 5:21PM CST
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $78.48 to a high of $79.73. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $79.13 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 80.36 (-0.65)
Financial Results, Facility Opening, and Management Changes - Research Reports on Norfolk, Cardinal, CSX, Viacom and Carnival
PR Newswire - Tue Nov 04, 8:10AM CST
Today, Analysts Review released its research reports regarding Norfolk Southern Corp. (NYSE: NSC), Cardinal Health Inc. (NYSE: CAH), CSX Corporation (NYSE: CSX), Viacom, Inc. (NASDAQ: VIAB) and Carnival Corporation (NYSE: CCL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7672-100free.
NSC: 114.82 (-0.56), CCL: 41.73 (-0.54), CAH: 80.36 (-0.65), CSX: 36.62 (-0.05), VIAB: 73.08 (-0.67)
How Can Health Plans Make MTM Services a Cornerstone Benefit for Their Members?
PR Newswire - Mon Nov 03, 8:41AM CST
Healthcare leaders are being pushed hard across the board to lower costs while raising quality. Medication Therapy Management (MTM) has been hailed by many, including the federal government, as one way to accomplish this important goal, especially in Medicare Part D. In fact, the Center for Medicare & Medicaid Services (CMS) calls MTM a "cornerstone" of Part D's future and a practice that will "serve as a model for achieving quality."
CAH: 80.36 (-0.65)
Cardinal Health (CAH) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Sat Nov 01, 9:37PM CDT
The following Cardinal Health (CAH) conference call took place on October 30, 2014, 08:30 AM ET. This is a transcript of that earnings call:
CAH: 80.36 (-0.65)
